Industry
Molecular Diagnostics Emerging Rapidly for Routine Patient Care
The success of molecular diagnostics will result from the commercialization of rapid, user-friendly, inexpensive, and high-quality tests and, together with the discovery of molecular-based therapeutics, will allow for more individualized disease management. More...13 Jan 2009
New
Gold Member
Collection and Transport System
PurSafe Plus®
Gold Member
Hematology Analyzer
Medonic M32B
Gel Cards
DG Gel Cards
In Other News
Competitive Intelligence Can Help Healthcare Companies in Uncertain Times
Pulmonary Biomarker Surfactant Protein-B Is Used for Diagnosis
DxS and Amgen Collaborate on Companion Diagnostic for Vectibix
Laboratories Consolidate Clinical Chemistry and Immunoassay Analyzers
Dako To Develop Companion Diagnostic for Cancer Therapy
Noninvasive Procedure Improves Success Rate of IVF
Nanogen and the French Diagnostic Company Elitech Merge
Facility for Span Nihon Kohden Diagnostics Inaugurated in India
Controls for Warfarin and Thrombophilia Introduced
Integrated DNA Technologies Opens Facility in Belgium
MTS Health Investors Purchases DNA Diagnostics Center
Molecular Diagnostics Segment Rapidly Growing
Qiagen Acquires Biosystems Unit from Biotage
Roche Constructs Diagnostics Facility Near Munich
BioMérieux Acquires Oncology and Theranostics Company
German Red Cross and Cerus Develop Erythrocyte System
Sequenom Acquisition of CMM Will Aid Test Commercialization
Interleukin Genetics and Alticor Agree on Expansion of Distribution Channels for Genetic Tests
Pall Corporation Acquires Molecular Diagnostics Manufacturer GeneSystems
Siemens Building Expansion Enables a Billion Diagnostic Tests Annually
CellaVision Introduces Analyzers into the Japanese Market
"Back-Door” Tactics May Transform IVD Industry
Nanogen to Merge with Private French Diagnostics Firm
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
